HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany’s OTC Pharmacy Market Grows Double Digits In 2022, Future Rocky But Positive

Executive Summary

A strong cough and cold season helped Germany's OTC market through pharmacy achieve double-digit growth in 2022, according to data from IQVIA. Looking ahead, Sempora Consulting sees this positive momentum continuing, with consumers motivated to prevent illness through self-care. However, inflation and generic competition are putting pressure on brand owners to show value for their more expensive products, especially in non-critical health categories. Sempora offers its advice to German companies for 2023. 

You may also be interested in...

Probiotics, Synbiotics May Help With Children’s Stomach Pain But Results Are Inconclusive

Probiotics and synbiotics may be more efficacious than placebo in reducing the severity and frequency of functional abdominal pain in children, concludes a recently published Cochrane Review. But the evidence is of low certainty,” the authors warn.

Prevention And Science Trends Driving Double-Digit Growth In APAC Prebiotics Market

“For consumers around the globe, and the APAC market is a prime example, there is an ongoing shift from reactivity to proactivity,” explains Clasado Biosciences David Mharakurwa. Alongside an increasing awareness of the links between gut health and wellness, such trends are driving strong growth in the region for nutraceuticals like Clasado’s Bimuno GOS. 

EU Packaging Regulation Presents Challenge And Opportunity For Consumer Health Industry

A proposed new European Union packaging regulation, which introduces environmental and labelling requirements and extended producer responsibility for medicines, medical devices and food supplements, could be challenging for the region's consumer health industry. But it could also be a spur to creativity, argues Chris Whitehouse, chairman and managing director of Whitehouse Communications.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts